
Cooper Companies (COO) Stock Forecast & Price Target
Cooper Companies (COO) Analyst Ratings
Bulls say
Cooper Companies is one of the leading eyecare companies in the US, with a diverse product portfolio that includes contact lenses, medical equipment, and women's health products. It has a significant market share in both the contact lens and IUD markets, and its ongoing strategic review may lead to potential separation of its two segments, providing additional value for its shareholders. Additionally, the company has shown strong financial performance with mid-single digit organic revenue and high-single digit EPS growth, and its focus on cost reduction and debt reduction will likely result in further margin improvement and EPS growth.
Bears say
Cooper Companies is facing increasing competition in the contact lens market and consumer weakness, along with investments in key product launches and currency headwinds that could negatively impact their financials in the near future. Additionally, the company's strategic review announced in October could result in a potential separation of its two segments, which could create dis-synergies and have a negative impact on their tax rate. While their CooperSurgical segment has shown improved growth, the company is still facing challenges such as constrained consumer spending and potential competition for their PARAGARD product. Overall, the company's outlook is not favorable due to these factors and potential risks.
This aggregate rating is based on analysts' research of Cooper Companies and is not a guaranteed prediction by Public.com or investment advice.
Cooper Companies (COO) Analyst Forecast & Price Prediction
Start investing in Cooper Companies (COO)
Order type
Buy in
Order amount
Est. shares
0 shares